THE VALUE OF COMBINATION CHEMOTHERAPY IN THE TREATMENT OF METASTATIC BREAST CANCER: A FIVE-YEAR EXPERIENCEKOLARIC K; TOMEK R; ROTH A et al.1980; PERIOD. BIOL.; ISSN 0031-5362; YUG; DA. 1980; VOL. 82; NO 2; PP. 181-188; ABS. CRO; BIBL. 32 REF.Article

SERUM ZINC LEVELS IN PATIENTS WITH MALIGNANT LYMPHOMAS = TAUX SERIQUES DU ZINC CHEZ LES MALADES ATTEINTS DE LYMPHOMES MALINSKOLARIC K; ROGULJIC A; IVANKOVIC G et al.1975; ACTA MED. IUGOSL.; YOUGOSL.; DA. 1975; VOL. 29; NO 4; PP. 331-338; ABS. SERBO-CROATE; BIBL. 18 REF.Article

CAP (cyclophosphamide, adriamycin, platinum) vs CMFVP (cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisolone) combination chemotherapy in untreated metastatic breast cancer: a preliminary report of a controlled clinical studyKOLARIC, K; ROTH, A; VUKAS, D et al.Cancer chemotherapy and pharmacology. 1984, Vol 13, Num 2, pp 142-144, issn 0344-5704Article

Living kidney donor with splenic artery aneurysmORLIC, P; DIMEC, D; MOZETIC, V et al.Transplantation proceedings. 1996, Vol 28, Num 1, issn 0041-1345, p. 368Conference Paper

Phase II study of 4'-epi-doxorubicin in patients wih untreated, extensive small cell lung cancerECKHARDT, S; KOLARIC, K; PAWLICKI, M et al.Medical oncology and tumor pharmacotherapy. 1990, Vol 7, Num 1, pp 19-23, issn 0736-0118, 5 p.Article

Spontaneous contrast echoes in pericardial effusion : sign of gas-producing infectionMATANA, A; MARVRIC, Z; VUKAS, D et al.The American heart journal. 1992, Vol 124, Num 2, pp 521-523, issn 0002-8703Article

Vascular complications after 725 kidney transplantations during 3 decadesORLIC, P; VUKAS, D; VALENCIC, M et al.Transplantation proceedings. 2003, Vol 35, Num 4, pp 1381-1384, issn 0041-1345, 4 p.Article

Combination chemotherapy with 5-fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer: an open Phase II studyKOLARIC, K; POTREBICA, V; VUKAS, D et al.Journal of cancer research and clinical oncology. 1988, Vol 114, Num 3, pp 301-305, issn 0171-5216Article

Unilateral pulmonary emphysema with secondary bronchomalacia caused by bronchogenic cyst in an infantAHEL, V; PALCEVSKI, G; DRESCIK, I et al.Pediatric pulmonology. 1994, Vol 18, Num 1, pp 58-60, issn 8755-6863Article

Randomized phase II trial of high-dose 4'-epi-doxorubicin + cyclophosphamide versus high-dose 4'-epi-doxorubicin + cisplatin in previously untreated patients with extensive small cell lung cancerKANITZ, E; KOLARIC, K; ECKHARDT, S et al.Oncology. 1992, Vol 49, Num 5, pp 327-332, issn 0030-2414Article